Magnetic Resonance Imaging in a Patient with Peripartum Cardiomyopathy

Kawano, Hiroaki; Tsuneto, Akira; Koide, Yuji; Tasaki, Hirofumi; Sueyoshi, Eijun; Sakamoto, Ichiro; Hayashi, Tomayoshi

doi:10.2169/internalmedicine.47.0316

Cited by 43 publications

(18 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[195][196][197][198] The use of gadolinium during a cardiac MRI is not recommended during pregnancy. 199 Although MRI can be useful in evaluating chamber size and function and determining the presence of LV thrombus, the role of cardiac MR in predicting recovery potential remains uncertain, and data are limited.…”

Section: E594mentioning

confidence: 99%

Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association

Bozkurt¹,

Colvin²,

Cook³

et al. 2016

Circulation

624

663

View full text Add to dashboard Cite

CLINICAL STATEMENTS AND GUIDELINEST he intent of this American Heart Association (AHA) scientific statement is to summarize our current understanding of dilated cardiomyopathies. There is special emphasis on recent developments in diagnostic approaches and therapies for specific cardiomyopathies. Recommendations in this document are based on published studies, published practice guidelines from the American College of Cardiology (ACC)/AHA 1 and other organizations, 2,3 and the multidisciplinary expertise of the writing group. Existing evidence in epidemiology, classification, diagnosis, and management of specific cardiomyopathies is usually derived from nonrandomized observational studies, registries, case reports, or expert opinion based on clinical experience, not large-scale randomized clinical trials or systematic reviews. Therefore, in this document, rather than using the standard ACC/AHA classification schema of recommendations and level of evidence, 4 we have included key management strategies at the end of each section and categorized our recommendations according to the level of consensus. Although the format of our recommendations might resemble the ACC/AHA classification of recommendations used in the ACC/AHA practice guidelines, because of the preponderance of expert opinion or level of evidence C evidence in our document, we elected to use different terminology to provide a distinction from the practice guidelines, in which stronger levels and quality of evidence with randomized clinical trials or meta-analyses are usually present. 4 The levels of evidence follow the AHA and ACC methods of classifying the level of certainty of the treatment effect. 4 DEfINITIoN of DILATED CArDIoMyopAThyThe term dilated cardiomyopathy (DCM) refers to a spectrum of heterogeneous myocardial disorders that are characterized by ventricular dilation and depressed myocardial performance in the absence of hypertension, valvular, congenital, or ischemic heart disease. 5 In clinical practice, the pathogenesis of heart failure (HF) has often been placed into 2 categories: ischemic and nonischemic cardiomyopathy. The term nonischemic cardiomyopathy has been interchangeably used with DCM. Although this approach might be practical, it fails to recognize that nonischemic cardiomyopathy can include cardiomyopathies caused by volume or pressure overload (such as hypertension or valvular heart disease) that are not conventionally accepted under the definition of DCM. 1,5 Again, in general practice and clinical research trials, the term ischemic cardiomyopathy is defined as cardiomyopathy caused by ischemic heart disease. Current use of ischemic cardiomyopathy terminology implies ventricular dilation and depressed myocardial contractility caused by ischemia or infarction. CLASSIfICATIoN of CArDIoMyopAThIESThe first classification on this topic categorized cardiomyopathies as heart muscle diseases with dilated (DCM), hypertrophic, restrictive, arrhythmogenic right ventricular (ARVC), or nonclassifiable cardiomyopathy in 1980. 5 Subse...

show abstract

Section: E594mentioning

confidence: 99%

Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association

Bozkurt¹,

Colvin²,

Cook³

et al. 2016

Circulation

624

663

View full text Add to dashboard Cite

show abstract

“…In PPCM, cardiac MRI provides more accurate quantification of chamber volumes and ventricular function, and is more sensitive in detecting LV thrombus than echocardiography (Mouquet, 2008;Srichai, 2006). At the present time, there are four case series with PPCM assessed by cardiac MRI (CaballeroBorrego, 2008;Kawano, 2008;Leurent, 2009;Mouquet, 2008). In only two of these studies the technique revealed myocardial inflammation.…”

Section: Investigation Of Peripartum Cardiomyopathymentioning

confidence: 93%

“…The interest for the technique is also suggested by the ability to differentiate PPCM from other forms of cardiomyopathy, like Tako-Tsubo or ischemic cardiomyopathy. The technique might be a useful method for guiding biopsy to the abnormal area (Leurent et al, 2009), and for prognostic stratification (Kawano et al, 2008). In his comment, Fett supports cardiac MRI for PPCM which is not responding to conventional therapy as long as late gadolinium enhancement is more likely to be present in these cases (Fett, 2009).…”

Section: Investigation Of Peripartum Cardiomyopathymentioning

confidence: 98%

Peripartum Cardiomyopathy: A Systematic Review

Aursulesei¹,

Datcu²

2012

Cardiomyopathies - From Basic Research to Clinical Management

View full text Add to dashboard Cite

“…(88) Some evidence exists for the usefulness of MRI for diagnosis, pathogenic and prognostic consideration in patients with PPCM. (89) Cardiac catheterisation can be used for evaluation of left ventricular function, obtaining endomyocardial biopsies and performing coronary angiography, but is not essential to diagnosis in most cases.…”

Section: Etiology and Pathogenesismentioning

confidence: 99%

Neglected cardiomyopathies in Africa

Mocumbi

2017

SAHJ

View full text Add to dashboard Cite

Size of the problemCardiomyopathies constitute a huge burden to both communities and health systems in Africa. Together with rheumatic heart disease, tuberculous pericarditis, systemic hypertension and its complications, cardiomyopathies are the major causes of heart disease in black African populations, causing great morbidity and mortality in young and economically active people (6,7) and being responsible for more than 20% of all admissions for cardiovascular diseases in both children and adults.EMF, the most common cardiomyopathy in African children and adolescents, shows great geographic variation with areas of higher incidence being the tropical regions of East, Central and West of the continent, (9) where it accounts for up to 20% of cases of heart failure. (5,7,10)

show abstract

Magnetic Resonance Imaging in a Patient with Peripartum Cardiomyopathy

Abstract: Abstract

Cited by 43 publications

References 28 publications

Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association

Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association

Peripartum Cardiomyopathy: A Systematic Review

Neglected cardiomyopathies in Africa

Contact Info

Product

Resources

About